Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: a comparison of Australian series.

Journal: Journal of medical imaging and radiation oncology

Published Date: Jan 15, 2015

Abstract

INTRODUCTION: We compare the results of modern external-beam radiotherapy (EBRT), using combined androgen deprivation and dose-escalated intensity-modulated radiotherapy with MRI-CT fusion and daily image guidance with fiducial markers (DE-IG-IMRT), with recently published Australian series of brachytherapy and surgery.

Authors

Shea William Wilcox

Radiation Oncology, North Coast Cancer Institute, Port Macquarie, New South Wales, Australia.
Noel J Aherne
Craig Steven McLachlan
Michael J McKay
Andrew J Last
Thomas P Shakespeare

Radiation Oncology, Mid North Coast Cancer Institute and University of New South Wales Rural Clinical School, Coffs Harbour, New South Wales, Australia.

Keywords

Aged Aged, 80 and over Androgen Antagonists Australia Brachytherapy Chemoradiotherapy Disease-Free Survival Humans Male Middle Aged Prevalence Prostatic Neoplasms Radiotherapy, Conformal Retrospective Studies Risk Factors Robotics Surgery, Computer-Assisted Survival Rate Treatment Outcome

External Resources

View on PubMed Access via DOI PubMed (25588566)

Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: a comparison of Australian series.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals